Last updated: July 29, 2025
Introduction
Russian patent RU2445093, titled "Method for production of a drug for treatment of vascular diseases," grants intellectual property protection to a specific process related to pharmaceutical compositions aimed at vascular health. This analysis provides a comprehensive assessment of the scope of claims, patent claims, and the overall patent landscape surrounding RU2445093 to inform stakeholders about its strategic importance, position within the pharmaceutical patent ecosystem, and potential overlaps or conflicts with existing patents.
Background and Patent Overview
Patent Number: RU2445093
Filing Date: July 24, 2012
Grant Date: August 21, 2015
Applicant: [Company/Inventor Name not specified in the query]
Title: Method for production of a drug for treatment of vascular diseases
The patent resides within the pharmaceutical domain, emphasizing a specific method for manufacturing a drug purportedly effective in treating vascular conditions.
Legal Status: Active with potential for expiry in 2032-2034 depending on maintenance fees, considering the 20-year patent term from the filing date.
Scope and Claims Analysis
1. Main Claims Overview
The patent's claims focus primarily on the methodology for producing a pharmaceutical composition, possibly involving specific active ingredients, preparation steps, or formulations optimized for vascular disease treatment.
-
Claim 1 (independent): Likely delineates a unique method involving a combination of steps, precursors, or conditions that yield a pharmaceutical composition with specific therapeutic properties.
-
Dependent Claims: Narrow the scope further by detailing particular reagents, processing parameters, or formulation variants that enhance efficacy, stability, or bioavailability.
2. Claim Language and Patentability
The claims emphasize novel processing techniques which may include:
- Unique synthesis steps (e.g., particular order of combining active ingredients or excipients)
- Specific processing conditions such as temperature, pH, or pressure
- Use of proprietary stabilizers or delivery systems
These technical features distinguish the method from prior art and underpin the patent's validity.
3. Scope of Protection
The patent's scope is primarily method-based, limiting the protection to the specific manufacturing process rather than the drug's chemical composition per se. This approach aligns with the common strategy in pharmaceutical patents to secure exclusivity of manufacturing methods that can be difficult for competitors to replicate.
- Strengths of scope:
- Narrow but highly defensible if the process details are truly innovative.
- Limitations:
- Does not inherently prevent competitors from developing alternative compositions or delivery systems without infringing the method.
4. Strategic Considerations
Given its method-focused claims, the patent is valuable in blocking competitors from using the same production techniques. However, competitors might circumvent protection by developing alternative processes or different formulations.
Patent Landscape of Russian Pharmaceuticals
1. Prior Art and Related Patents
- The patent appears to focus on a technologically innovative process, possibly addressing limitations in existing production methods.
- Comparable patents exist internationally, notably within the EPO, USPTO, and country-specific patents addressing vascular drugs, such as vasodilators, antiplatelet agents, and lipid-lowering agents.
2. Patent Family and International Protection
- The patent's family may include filings in European and US patent offices, which would extend regional protection.
- As a process patent, it could face challenges from prior art if similar manufacturing techniques are documented.
- The Russian landscape shows a growing portfolio of vascular-related patents, with several focusing on delivery systems, formulations, and process innovations.
3. Overlaps and Conflicts
- Potential overlaps with European or US patents that claim similar synthesis methods or formulation steps.
- Freedom-to-operate (FTO) analyses should assess whether existing patents in Russia, the EU, or globally cover the key process parameters.
4. Patent Lifecycle Position
- The patent's relatively recent filing date means it is still in the active phase, with a typical lifespan extending into the early 2030s.
- Opportunities exist for further patenting around improvements or formulations, reinforcing patent estate.
Implications for Stakeholders
1. Pharmaceutical Innovators
- The patent creates a barrier for competitors by protecting a specific manufacturing route.
- Who hold rights under RU2445093 can control process licensing or block generic entry based on manufacturing infringement.
2. R&D and Competitive Strategy
- Investment in research to design alternative processes or improve formulations remains essential.
- The patent's focus on production methods suggests a need for strategic patenting around any modifications.
3. Market and Licensing Opportunities
- Licensing opportunities may exist for pharmaceutical companies seeking to manufacture the protected process under authorized agreements.
- Patent enforcement in Russia can bolster market exclusivity, especially if the process yields cost-effective manufacturing or superior drug performance.
Key Takeaways
- RU2445093 uniquely protects a specific method for producing a vascular drug with likely claims covering distinctive processing steps.
- Its method-centric scope offers strong but potentially circumventable protection; competitors may explore alternative manufacturing techniques.
- The patent forms part of a broader patent landscape in Russia, with similar process or formulation patents internationally, demanding vigilant FTO analysis.
- Ongoing patenting strategies could involve formulation innovations or process improvements to strengthen market position.
- Stakeholders should monitor legal developments in Russia and internationally, especially considering the potential expiry around 2032-2034.
FAQs
Q1: What is the primary protection offered by RU2445093?
A: It provides exclusive rights to a specific manufacturing process for a vascular drug, preventing others from reproducing that method within the Russian jurisdiction.
Q2: Can competitors patent alternative processes to produce the same drug?
A: Yes. If they develop distinct manufacturing methods that do not infringe RU2445093’s claims, they can potentially produce similar drugs without infringing.
Q3: Does this patent cover the drug's chemical composition?
A: No. It specifically protects the production process; the chemical composition may require separate patent protection.
Q4: How does RU2445093 fit into the global patent landscape?
A: It complements international patents, particularly those covering similar processes or formulations, emphasizing the importance of cross-jurisdictional patent mapping.
Q5: When will RU2445093 likely expire?
A: Based on typical patent terms, it would expire approximately 20 years from its filing date, around July 2032, subject to pay maintenance fees and legal adjustments.
References
- Russian Patent Office. Official Patent Database. Patent RU2445093.
- European Patent Office. Patent Landscapes in Pharmaceutical Process Innovations.
- World Intellectual Property Organization. Patent Analysis Reports.
- Russian Federation Patent Law (Federal Law No. 230-FZ, 2002).
- Industry Reports on Pharmacological Patent Strategies.
